Mucopolysaccharidoses type IVA (Morquio disease) is a rare, autosomal recessive lysosomal storage disease that causes both obstructive and restrictive airway pathology, with respiratory failure being the primary cause of death. In this retrospective, longitudinal, repeated-measures cohort study, descriptive statistics and non-parametric correlation were performed for demographic, respiratory function and oximetry (sleep studies) variables over a study period from January 2009 to December 2018. Composite clinical endpoints used in this study for evaluating pulmonary function included spirometry variables (FEV1, FEV1 [%Pred] FVC, FVC [%Pred] and FEV1/FVC), 6MWT and oximetry variables (median %Spo2, ODI 3%, mean nadir 3%, ODI 4%, mean nadir ...
BACKGROUND: Mucopolysaccharidosis (MPS) IVA, also known as Morquio A syndrome, is a rare autosomal r...
ObjectiveTo present long-term respiratory function outcomes from an open-label, multi-center, phase ...
SummaryThe mucopolysaccharidoses are comprised of hereditary disorders joined by errant degradation ...
AbstractBackgroundMucopolysaccharidosis (MPS) are classified into seven clinical types based on elev...
(1) Background: Mucopolysaccharidoses (MPS) are a heterogeneous group of lysosomal storage disorders...
To study the sleep characteristics, pulmonary function, and their relationships in an enzyme naive p...
Pulmonary function is impaired in untreated mucopolysaccharidosis type VI (MPS VI). Pulmonary functi...
Pulmonary function is impaired in untreated mucopolysaccharidosis type VI (MPS VI). Pulmonary functi...
Objective: To examine respiratory muscle function among late-onset Pompe disease (LOPD) patients in ...
Morquio A syndrome (mucopolysaccharidosis IVA, MPS IVA) is a lysosomal storage disease caused by a d...
Item does not contain fulltextOBJECTIVE: To assess the CT findings of the airway in children with mu...
Aim:Mucopolysaccharidosis Type IVA (MPS IVA), Morquio A, is caused by the deficiency in lysosomal en...
Little is understood about the clinical course and prognosis of patients with Sauropus androgynus-re...
WOS: 000406928300004Aim: Mucopolysaccharidosis (MPS) type VI or Maroteaux Lamy syndrome is an autoso...
Background: This post hoc subanalysis examined outcomes in adult patients with Morquio A (mucopolysa...
BACKGROUND: Mucopolysaccharidosis (MPS) IVA, also known as Morquio A syndrome, is a rare autosomal r...
ObjectiveTo present long-term respiratory function outcomes from an open-label, multi-center, phase ...
SummaryThe mucopolysaccharidoses are comprised of hereditary disorders joined by errant degradation ...
AbstractBackgroundMucopolysaccharidosis (MPS) are classified into seven clinical types based on elev...
(1) Background: Mucopolysaccharidoses (MPS) are a heterogeneous group of lysosomal storage disorders...
To study the sleep characteristics, pulmonary function, and their relationships in an enzyme naive p...
Pulmonary function is impaired in untreated mucopolysaccharidosis type VI (MPS VI). Pulmonary functi...
Pulmonary function is impaired in untreated mucopolysaccharidosis type VI (MPS VI). Pulmonary functi...
Objective: To examine respiratory muscle function among late-onset Pompe disease (LOPD) patients in ...
Morquio A syndrome (mucopolysaccharidosis IVA, MPS IVA) is a lysosomal storage disease caused by a d...
Item does not contain fulltextOBJECTIVE: To assess the CT findings of the airway in children with mu...
Aim:Mucopolysaccharidosis Type IVA (MPS IVA), Morquio A, is caused by the deficiency in lysosomal en...
Little is understood about the clinical course and prognosis of patients with Sauropus androgynus-re...
WOS: 000406928300004Aim: Mucopolysaccharidosis (MPS) type VI or Maroteaux Lamy syndrome is an autoso...
Background: This post hoc subanalysis examined outcomes in adult patients with Morquio A (mucopolysa...
BACKGROUND: Mucopolysaccharidosis (MPS) IVA, also known as Morquio A syndrome, is a rare autosomal r...
ObjectiveTo present long-term respiratory function outcomes from an open-label, multi-center, phase ...
SummaryThe mucopolysaccharidoses are comprised of hereditary disorders joined by errant degradation ...